Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19

MLA

Filippo Liviero, et al. “Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19.” Frontiers in Medicine, vol. 8, Nov. 2021. EBSCOhost, https://doi.org/10.3389/fmed.2021.753819.

APA

Filippo Liviero, Manuela Campisi, Paola Mason, & Sofia Pavanello. (2021). Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.753819

Chicago

Filippo Liviero, Manuela Campisi, Paola Mason, and Sofia Pavanello. 2021. “Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19.” Frontiers in Medicine 8 (November). doi:10.3389/fmed.2021.753819.